ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,005,888 | +51.7% | 24,800 | +148.0% | 0.14% | +1015.4% |
| Q4 2021 | $663,000 | -85.8% | 10,000 | -86.6% | 0.01% | -90.8% |
| Q3 2021 | $4,673,000 | +1611.7% | 74,849 | +2168.2% | 0.14% | +1320.0% |
| Q2 2021 | $273,000 | -97.2% | 3,300 | -97.7% | 0.01% | -95.9% |
| Q1 2021 | $9,668,000 | +1160.5% | 145,800 | +1358.0% | 0.24% | +1513.3% |
| Q4 2020 | $767,000 | +78.0% | 10,000 | 0.0% | 0.02% | -6.2% |
| Q3 2020 | $431,000 | +1624.0% | 10,000 | +400.0% | 0.02% | +166.7% |
| Q4 2018 | $25,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |